Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
16.93
0.07 (0.42%)
At close: Aug 15, 2025, 3:59 PM
16.95
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT
Spyre Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 688K | 198K | 168K | 174K | 625K | 1.36M | 3.64M | 1.4M | 13.7M | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -41.94M | -53.57M | -61.25M | -55.39M | -44.15M | -47.77M | -45.91M | -18.34M | -159.25M | -18.81M | -19.16M | -18.75M | -22.42M | -24.44M | -20.44M | -20.29M | -6.71M | -18.21M |
Interest Income | 5.87M | 6.49M | 5.78M | 5.18M | 5.92M | 4.43M | 4.13M | 1.25M | 350K | 420K | 410K | 288K | 104K | 35K | 34K | 36K | 19K | 22K |
Pretax Income | -36.72M | -44.79M | -56.3M | -69.01M | -38.84M | -43.83M | -63.18M | -40.1M | -217.07M | -18.46M | -18.78M | -18.44M | -22.31M | -24.44M | -20.42M | -20.28M | -6.74M | -18.22M |
Net Income | -36.72M | -44.77M | -56.3M | -69.03M | -38.84M | -43.86M | -63.18M | -40.11M | -217.08M | -18.42M | -18.82M | -18.23M | -22.32M | -24.44M | -20.45M | -20.31M | -6.83M | -18.22M |
Selling & General & Admin | 11.79M | 11.94M | 10.77M | 10.65M | 11.51M | 12.85M | 14.07M | 8.58M | 12.06M | 5.23M | 5.08M | 6.95M | 7.67M | 8.82M | 7.3M | 6.84M | 6.82M | 6.35M |
Research & Development | 40.15M | 41.62M | 50.48M | 44.74M | 32.64M | 34.93M | 33.68M | 24.66M | 17.39M | 13.78M | 14.25M | 11.98M | 15.37M | 16.98M | 16.78M | 14.85M | 13.58M | 11.86M |
Other Expenses | -10M | n/a | n/a | n/a | n/a | n/a | -1.84M | -14.91M | 130.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 41.94M | 53.57M | 61.25M | 55.39M | 44.15M | 47.77M | 45.91M | 18.34M | 159.93M | 19M | 19.33M | 18.93M | 23.05M | 25.8M | 24.09M | 21.69M | 20.4M | 18.21M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.94M | 53.57M | 61.25M | 55.39M | 44.15M | 47.77M | 45.91M | 18.34M | 159.93M | 19M | 19.33M | 18.93M | 23.05M | 25.8M | 24.09M | 21.69M | 20.4M | 18.21M |
Income Tax Expense | n/a | -15K | 1K | 18K | n/a | 32K | n/a | 3K | 7K | -36K | 38K | -209K | 9K | n/a | 23K | 26K | 92K | n/a |
Shares Outstanding (Basic) | 60.7M | 60.27M | 47.03M | 50.89M | 45.32M | 36.51M | 6.9M | 4.29M | 3.82M | 3.77M | 2.61M | 3.77M | 3.29M | 2.64M | 1.97M | 2.63M | 2.63M | 2.62M |
Shares Outstanding (Diluted) | 60.7M | 60.27M | 47.03M | 50.89M | 45.32M | 36.51M | 6.9M | 4.29M | 3.82M | 3.77M | 2.61M | 3.77M | 3.29M | 2.64M | 1.97M | 2.63M | 2.63M | 2.62M |
EPS (Basic) | -0.6 | -0.13 | -0.15 | -1.36 | -0.86 | -1.2 | -11.29 | -9.34 | -56.79 | -4.89 | -7.2 | -4.84 | -6.79 | -9.26 | -10.36 | -7.72 | -2.6 | -6.94 |
EPS (Diluted) | -0.6 | -0.13 | -0.15 | -1.36 | -0.86 | -1.2 | -11.29 | -9.34 | -56.79 | -4.89 | -7.2 | -4.84 | -6.79 | -9.26 | -10.36 | -7.72 | -2.6 | -6.94 |
EBITDA | -51.94M | -53.57M | -61.25M | -55.39M | -44.15M | -47.77M | -47.75M | -33.24M | -28.34M | -18.26M | -18.78M | -18.25M | -21.85M | -24.04M | -20.03M | -19.88M | -6.31M | -17.85M |
EBIT | -51.94M | -53.57M | -61.25M | -55.39M | -44.15M | -47.77M | -47.75M | -33.24M | -28.76M | -18.81M | -19.16M | -18.75M | -22.42M | -24.44M | -20.44M | -20.29M | -6.71M | -18.21M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | -220K | n/a | 416K | 548K | 385K | 502K | 569K | 403K | 411K | 412K | 398K | 355K |